We are thrilled to announce the strategic collaboration between Atinary and Takeda, the largest Japanese pharmaceutical company, to drive innovation in healthcare.
This partnership brings together our complementary expertise, paving the way for innovative AI solutions poised to transform pharmaceutical R&D and accelerate drug discovery. Through this collaboration, Takeda will leverage Atinary’s leading AI Self-Driving Labs technology, that combined with its expertise in R&D and drug discovery aim to create a more robust and efficient drug development process, ultimately benefiting patients worldwide.
At Atinary, we are committed to harnessing the power of AI, data science, robotics, and cloud computing to dramatically accelerate the discovery and development of breakthrough molecules. Our collaboration with Takeda Pharmaceuticals is a significant step towards achieving this goal.
We look forward to working together to revolutionize the field of drug development and improve healthcare outcomes.
In the news
- BioAlps, Biôpole: Atinary and Takeda collaborate to drive innovation in healthcare
- Startupticker.ch: Atinary Technologies joins forces with Takeda
- Swisstrade, Geneva and Greater Bern area: Atinary and Takeda forge a strategic alliance to advance healthcare innovation
